Amundi Asset Management US’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Amundi Asset Management US’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-162,859	Closed	-$22.2M	–	1642
2020 Q3	$22.2M	Buy	162,859 +33,716	+26%	+$3.58M	0.02%	524
2020 Q2	$12.5M	Buy	129,143 +127,843	+9,834%	+$10.7M	0.01%	631
2020 Q1	$61K	Hold	1,300	–	–	﹤0.01%	1462
2019 Q4	$95K	Hold	1,300	–	–	﹤0.01%	1560
2019 Q3	$68K	Hold	1,300	–	–	﹤0.01%	1568
2019 Q2	$65K	Hold	1,300	–	–	﹤0.01%	1595
2019 Q1	$68K	Buy	+1,300	New	+$59.9K	﹤0.01%	1567

Amundi Asset Management US's MYOK Position: Q4 2020 in Review

Amundi Asset Management US sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 162,859 shares — an estimated $22.2M sold.

Amundi Asset Management US first reported a position in MYOK in Q1 2019 and held it in 7 quarters. The position peaked at $22.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Amundi Asset Management US reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Amundi Asset Management US sold 162,859 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $22.2M.
Amundi Asset Management US first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 7 quarters.
Amundi Asset Management US's MyoKardia, Inc. Common Stock position peaked at $22.2M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.